Global Academic and Non-Profit Partnering Terms and Agreements 2021-2026

Academic and Non-Profit Partnering Terms and Agreements 2021-2026

Understand how pharmaceutical and biotechnology companies partner with universities, research institutes and non-profit organizations using intelligence from 2,448 real-world agreements.

Academic and Non-Profit Partnering Terms and Agreements 2021-2026 provides comprehensive intelligence on 2,448 partnerships involving pharmaceutical and biotechnology companies, universities, academic research institutions and non-profit organizations.

Academic and non-profit organizations play a fundamental role in life sciences innovation, generating new science, technologies, therapeutic approaches and intellectual property that can progress through collaboration with industry.

These relationships take many forms. They can begin with early research or evaluation, develop into sponsored research or technology access agreements, or lead to licensing, co-development and commercialization partnerships.

This report brings the full spectrum of academic and non-profit partnering activity together in one resource, enabling users to understand who is partnering, which organizations are most active, what types of agreements are being used, which technologies and therapeutic areas are attracting activity, and what financial and contractual terms have been disclosed.

Rather than focusing on a single deal type, the report provides a cross-industry view of how companies engage with academic and non-profit innovation across discovery, development and commercialization.

It provides a practical intelligence and benchmarking resource for business development, licensing, external innovation, technology transfer, search and evaluation, R&D strategy, corporate strategy and legal teams involved in academic-industry partnering.

Understand how industry partners with academia and non-profit organizations

The report analyzes academic and non-profit partnering from 2021 to 2026, including:

• Trends in partnering activity by year
• Most active academic and non-profit dealmakers
• Most active industry partners
• Partnering activity by deal type
• Therapy area
• Technology type
• Stage of development
• Leading partnerships by disclosed value
• Financial terms where available
• How academic-industry partnering activity is evolving
• This provides a market-wide view of the different ways pharmaceutical and biotechnology companies are accessing academic research and external innovation.
• Compare the full range of partnership structures
• Academic-industry relationships can be structured very differently depending on the maturity of the science, objectives of the parties and future commercial opportunity.

The report spans multiple partnership types, enabling users to investigate approaches including:

• Research collaborations
• Sponsored research
• Licensing agreements
• Technology access
• Option and evaluation agreements
• Development collaborations
• Commercialization partnerships
• Manufacturing and supply arrangements
• Other multi-component partnering structures
• This enables users to compare different routes for accessing academic innovation rather than looking at licensing or research collaboration in isolation.
• Identify leading universities, research institutions and industry partners
• The report identifies the most active organizations in academic and non-profit partnering and provides detailed transaction histories that enable users to investigate their previous activity.

This can help users identify:

• Universities and research institutions with active industry partnering programs
• Non-profit organizations involved in life sciences innovation
• Pharmaceutical and biotechnology companies actively sourcing academic innovation
• Organizations repeatedly partnering in particular technologies or therapeutic areas
• Potential industry partners for academic technologies and assets
• Potential academic collaborators for companies seeking external innovation
• Historical activity can provide valuable evidence of which organizations have demonstrated a willingness to work together and the types of opportunities that attract their interest.
• Understand where academic innovation is attracting industry interest
• The report analyzes academic and non-profit partnering by therapy area, technology type and stage of development.

This enables users to investigate:

• Which therapeutic areas are generating significant academic-industry activity
• Technologies attracting external innovation interest
• The development stages at which companies engage with academic research
• How partnering approaches differ across technologies and therapeutic fields
• Organizations repeatedly active in particular areas
• For external innovation and search teams, this can provide valuable context around where industry interest is developing and which organizations are participating.
• Benchmark academic and non-profit deal financials
• Academic partnerships vary substantially in financial structure according to the nature of the research, intellectual property, rights granted and development potential.

The report provides analysis of disclosed financial terms, including:

• Headline deal values
• Upfront payments
• Milestone payments
• Royalty rates
• Users can investigate the individual agreements behind these benchmarks to understand the structure and circumstances surrounding the disclosed economics.
• This provides useful real-world reference points when evaluating or preparing academic partnerships.
• Financial benchmarks should be considered alongside the rights granted, development stage and structure of comparable agreements rather than as standalone averages, and the report provides the underlying transaction intelligence needed to establish that context.
• Understand how academic partnerships allocate rights and responsibilities
• Academic and non-profit agreements frequently involve detailed provisions concerning intellectual property, research responsibility, publication rights and future commercialization.

Depending on the transaction and available disclosure, users can investigate areas including:

• Research responsibilities
• Sponsored research funding
• Intellectual property ownership
• Licensing and option rights
• Exclusivity
• Rights to research results
• Patent prosecution and maintenance
• Development responsibilities
• Commercialization rights
• Milestones and royalties
• Publication rights
• Governance
• Term and termination provisions
• These real-world examples provide useful reference points when structuring new relationships between industry and research institutions.
• Learn from real-world academic and non-profit contracts
• Where publicly available, the report provides access to underlying contract documents for selected partnerships.

These agreements can provide substantially more detail than press releases alone, allowing users to examine how companies and research institutions have documented matters including:

• Intellectual property ownership and licensing
• Research scope and responsibilities
• Funding
• Option and commercialization rights
• Exclusivity
• Milestone triggers
• Royalty provisions
• Publication and confidentiality
• Governance
• Termination and continuing rights
• For business development, technology transfer and legal teams, access to real agreement language provides valuable insight into how comparable academic-industry partnerships have been structured in practice.
• Comprehensive academic and non-profit deal directory
• The report includes a comprehensive directory of 2,448 academic and non-profit partnering agreements, providing an extensive resource for identifying relevant precedent transactions and organizations.

Deals can be investigated by:

• Company or institution
• Stage of development
• Deal type
• Therapy area
• Technology type
• Deal value
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and Licensing teams
• Identify academic innovation opportunities, comparable agreements and organizations with relevant partnering experience.
• External Innovation and Search & Evaluation teams
• Identify universities, research institutes and non-profits active in technologies and therapeutic areas of strategic interest.
• Technology Transfer and Academic Licensing teams
• Understand how other institutions are partnering with industry, identify potential commercial partners and benchmark comparable agreements.
• Pharmaceutical and Biotechnology Companies
• Understand how peer companies access academic research and which institutions are particularly active in relevant areas.
• Universities, Research Institutes and Non-Profit Organizations
• Identify companies with demonstrated interest in academic innovation and investigate precedent transactions involving comparable technologies and assets.
• Corporate and R&D Strategy teams
• Understand how academic collaboration contributes to external innovation and pipeline development strategies.
• Legal and Transaction teams
• Review publicly available agreements covering intellectual property, research responsibilities, licensing, option rights, financial terms and other negotiated provisions.
• Turn market-wide academic partnering intelligence into organization-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying academic and non-profit partnering intelligence to the customer's own research interests, technologies, assets or strategic objectives.
• Depending on requirements, this can include relevant precedent agreements, prospective academic or industry partners, active institutions, technology and therapy-area analysis, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.